Alester Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 9 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.50 M
- Revenue Growth 29.86%
- Profit Growth 82.99%
- Ebitda 384.12%
- Net Worth 34.92%
- Total Assets 26.92%
About Alester Pharma
Alester Pharma Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 November 2015 (Nine years and two months 14 days old ). Its registered office is in Chandigarh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹7.50 M.
Rajeev Matta, Kamna Matta, Adesh Saini, and One other member serve as directors at the Company.
Company Details
-
Location
Chandigarh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232CH2015PTC035840
-
Company No.
035840
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Nov 2015
-
Date of AGM
28 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
What products or services does Alester Pharma Private Limited offer?
Alester Pharma Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibacterial Drugs, Brain & Nervous System Drugs, Antiepileptic Drugs, Cardiovascular Drugs & Medication, Blood Pressure Medicine, Antifungal Injection, Tablet & Syrup, Respiratory System Drugs, Anti Asthma Drug, Cough Syrup.
Who are the key members and board of directors at Alester Pharma?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeev Matta
|
Director | 27-Nov-2015 | Current |
|
Kamna Matta
|
Director | 27-Nov-2015 | Current |
|
Adesh Saini
|
Director | 27-Nov-2015 | Current |
|
Sonia Taluja
|
Director | 27-Nov-2015 | Current |
Financial Performance of Alester Pharma.
Alester Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 29.86% increase. The company also saw a substantial improvement in profitability, with a 82.99% increase in profit. The company's net worth Soared by an impressive increase of 34.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alester Pharma?
In 2021, Alester Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Uniphar Biotech Private LimitedRajeev Matta, Kamna Matta and 1 more are mutual person
-
Abiz Pharma Private LimitedRajeev Matta, Kamna Matta and 1 more are mutual person
-
Arovea Lifesciences Private LimitedRajeev Matta and Adesh Saini are mutual person
Charges (Loans)
₹7.50 M
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 0.75 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Mar 2024 | Canara Bank | ₹7.50 M | Open |
How Many Employees Work at Alester Pharma?
Unlock and access historical data on people associated with Alester Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alester Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alester Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.